PrEP (Pre-Exposure Prophylaxis)
Is a comprehensive HIV prevention strategy that involves the daily use of antiretroviral medications to reduce the risk of HIV infection in HIV-negative individuals. In July 2012, the US Food and Drug Administration approved the use of Truvada (TDF/FTC) for use as PrEP in HIV prevention in sexually active HIV–negative individuals. PrEP should be used in conjunction with other prevention methods to reduce the risk of infection.
PrEP Resources:
(All links open in a new window)
CDC PrEP
http://www.cdc.gov/hiv/prep/
CDC PrEP Fact Sheet
http://www.cdc.gov/hiv/prep/pdf/PREPfactsheet.pdf
Truvada for PrEP Fact Sheet
http://www.fda.gov/downloads/NewsEvents/Newsroom/FactSheets/UCM312279.pdf
PrEP Webinar (HIV Prevention Program, HIV/AIDS and Hepatitis Section, FL DOH)
http://www.doh.state.fl.us/Disease_ctrl/aids/prevention/PrEP_Science_Webinar.pdf
AETC- PrEP
http://www.aids-ed.org/aidsetc?page=home-search&post=1&SearchEntry=PrEP
AIDSinfo- PrEP
http://aidsinfo.nih.gov/Guidelines
AIDS.gov
http://search.aids.gov/search?q=PrEP&entqr=0&output=xml_no_dtd&sort=date%3AD%3AL%3Ad1&ud=1&client=aids_gov&oe=UTF-8&ie=UTF-8&proxystylesheet=aids_gov&site=aids_gov
